Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
NCT04772456
Summary
The purpose of this study is to examine the safety and feasibility of performing hyperpolarized metabolic MRI in the diagnosis of brain tumor. This study will also assess the accuracy of hyperpolarized metabolic MRI to diagnose intermediate to patients with infiltrating gliomas and examine the added utility of metabolic MRI over standard MRI imaging The FDA is allowing the use of hyperpolarized \[1-13C\] pyruvate (HP 13C-pyruvate) in this study. Up to 5 patients may take part in this study at the University of Maryland, Baltimore (UMB).
Eligibility
Inclusion Criteria: * • Patients with a new brain lesion interpreted as suspected infiltrating gliomas including but not limited to (diffuse astrocytoma WHO grade 2; oligodendroglioma WHO grade 2 and 3; anaplastic astrocytoma WHO grade 3; astrocytoma WHO grade 4), OR, patients with prior history of infiltrating glioma scheduled for surgery for tumor biopsy or resection. * Ages 18-80, including male and female * Suitable to undergo contrast-enhanced MRI * Negative serum pregnancy test Exclusion Criteria: * Inability to undergo MRI scan * Inability to receive IV contrast secondary to severe reaction or renal insufficiency.
Conditions2
Interventions1
Locations1 site
Find trials near these locations
Related trials
- Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body — National Heart Centre Singapore
- Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS) — Sunnybrook Health Sciences Centre
- Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors — Robert Bok, MD, PhD
- Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer — University of California, San Francisco
- Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors — University of California, San Francisco
- Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer — Ivan de Kouchkovsky, MD
- HP Pyruvate MRI in Cancers — University of Maryland, Baltimore
- Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging — University of Maryland, Baltimore
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04772456